Abstract
The efficacy of intravenous laserotherapy in 850 patients with various clinical forms of ischemic heart disease including 349 patients with chronic ischemic heart disease, treated by means of helium-neon irradiation, -tocopherol, solcoseril and mildronat, is studied. Faster reverse development of the pain syndrome, high readaptation to physical loads are detected in patients treated with intravenous laserotnerapy and -tocopherol, intravenous laserotherapy, -tocopherol and seril. The pronounced antiarrhythmic effect is observed in the group treated with solcoseril. The necessity of the medicamental cover of laserotherapy in patients with ischemic heart disease especially in an increase of exposition and power of the light flow of helium-neon laser, as well as the dynamic control of parameters of coagulation, hemostasis, microcirculation and peroxide oxidation of lipoids is emphasized.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
